Omadacycline in Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms

被引：0
|
作者：
不详
机构：
来源：
AMERICAN HEALTH AND DRUG BENEFITS | 2018年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：489 / 489
页数：1
相关论文
共 50 条
  • [1] Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms
    Mendes, Rodrigo E.
    Huband, Michael D.
    Streit, Jennifer M.
    Castanheira, Mariana
    Flamm, Robert K.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 97 (03)
  • [2] In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms
    Pfaller, Michael A.
    Li, Li
    Liu, Qingmei
    Zhang, Jay
    Huband, Michael D.
    Lindley, Jill M.
    Mendes, Rodrigo E.
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (04):
  • [3] In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates
    Zeng, Weiliang
    Zhang, Xiaotuan
    Liu, Yan
    Zhang, Yi
    Xu, Mengxin
    Wang, Sipei
    Sun, Yao
    Zhou, Tieli
    Chen, Lijiang
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [4] In vitro activity of omadacycline against clinical isolates of Nocardia
    Pham, Jonathan
    Benefield, Russell J.
    Baker, Natali
    Lindblom, Shane
    Canfield, Nicholas
    Gomez, Carlos A.
    Fisher, Mark
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (05)
  • [5] Minimal inhibitory concentration of omadacycline and doxycycline against bacterial isolates with known tetracycline resistance determinants
    Fluit, Ad C.
    van Gorkum, Sjoukje
    Vlooswijk, Judith
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 94 (01) : 78 - 80
  • [6] In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China
    Yang, Yanmei
    Bian, Lijun
    Hang, Xudong
    Yan, Caiwang
    Huang, Yan
    Ye, Feng
    Zhang, Guoxin
    Jin, Guangfu
    Bi, Hongkai
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 98 (03)
  • [7] In Vitro Activity of New Tetracycline Analogues Eravacycline and Omadacycline Against Drug-Resistant Mycobacterium Abscessus Clinical Isolates
    Kaushik, A.
    Nuermberger, E. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [8] In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
    Kaushik, Amit
    Ammerman, Nicole C.
    Martins, Olumide
    Parrish, Nicole M.
    Nuermberger, Eric L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (06)
  • [9] In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms
    Morosini, MI
    Cantón, R
    Loza, E
    Negri, MC
    Galán, JC
    Almaraz, F
    Baquero, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2427 - 2431
  • [10] In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile
    Begum, Khurshida
    Basseres, Eugenie
    Miranda, Julie
    Lancaster, Chris
    Gonzales-Luna, Anne J.
    Carlson, Travis J.
    Rashid, Tasnuva
    Eyre, David W.
    Wilcox, Mark H.
    Alam, M. Jahangir
    Garey, Kevin W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (08)
12345